Back to Cancer Australia's website

Cancer Australia

Select a guideline

Recommendations for use of Chemotherapy

for the treatment of advanced breast cancer

JULY 2010 | Incorporates published evidence to December 2009

A CLINICAL PRACTICE GUIDELINE DEVELOPED BY NATIONAL BREAST AND OVARIAN CANCER CENTRE (NBOCC)*
This document supplements guideline recommendation 25 on the use of chemotherapy for the management of advanced breast cancer contained in the National Breast Cancer Centre (NBCC)* Clinical practice guidelines for the management of advanced breast cancer, 2nd edition, 2001 (pages 9-10).1

ISBN Print: 978-1-74127-136-2 Online: 978-1-74127-137-9 CIP: 616.99449061
Cancer Australia 2011

* In February 2008, National Breast Cancer Centre (NBCC), incorporating the Ovarian Cancer Program, changed its name to National Breast and Ovarian Cancer Centre (NBOCC). In July 2011, NBOCC amalgamated with Cancer Australia to form a single national agency, Cancer Australia, to provide leadership in cancer control and improve outcomes for Australians affected by cancer.

Purpose

This guideline includes statements and recommendations based on available, high-level evidence about the use of chemotherapy for the treatment of advanced breast cancer. The guideline provides health professionals with information designed to help them make management recommendations for improved patient outcomes. NBOCC* also develops information specifically for consumers about the diagnosis and treatment of advanced (secondary) breast cancer.

Endorsed by:

* In February 2008, National Breast Cancer Centre (NBCC), incorporating the Ovarian Cancer Program, changed its name to National Breast and Ovarian Cancer Centre (NBOCC). In July 2011, NBOCC amalgamated with Cancer Australia to form a single national agency, Cancer Australia, to provide leadership in cancer control and improve outcomes for Australians affected by cancer.

Related Links

Published using CeCC Docbook Manager